This article addresses the significant challenge of Variants of Uncertain Significance (VUS) in patients lacking a contributive family history.
This comprehensive guide demystifies Markov Chain Monte Carlo (MCMC) Gibbs sampling for Bayesian "alphabet" models (e.g., MCP-Mod, Bayesian model averaging) in drug development.
This article provides a comparative analysis of Multiplex Assays of Variant Effect (MAVEs) and traditional single-variant functional assays, tailored for researchers and drug development professionals.
This article explores the application of the MAP-Elites algorithm in designing evolutionary algorithms (EAs) for biomedical research, focusing on drug development.
This comprehensive guide provides researchers, scientists, and drug development professionals with an in-depth understanding of MAGeCK, the essential computational tool for analyzing CRISPR-Cas9 knockout and CRISPRi/a screening data.
This article provides a detailed comparative analysis of linked-read exome sequencing (LR-WES) and standard whole-exome sequencing (WES) for detecting structural variants (SVs), a critical but historically challenging class of genomic...
This article provides a comprehensive comparison of L1 (Lasso) and L-infinity penalty functions for researchers and drug development professionals.
This article provides a comprehensive resource for researchers performing RNA-seq analysis, detailing the theory, application, and optimization of the Kallisto and Salmon tools for transcript-level quantification.
This comprehensive guide demystifies the entire RNA sequencing (RNA-seq) workflow for biomedical researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on integrating Copy Number Variation (CNV) analysis with Whole Exome Sequencing (WES) Variant of Uncertain Significance (VUS) interpretation.